Mount Sinai DoctorsTreats Adults
Accepting New Patients
Bridget Marcellino, MD, PhD
Cancer (Oncology), Hematology-Oncology
About Me
Bridget K. Marcellino, MD, PhD is an assistant professor in the Department of Medicine, Division of Hematology & Oncology at the Icahn School of Medicine at Mount Sinai. She is a physician scientist who is focused on elucidating the mechanisms driving the formation and progression of myeloid malignancies, with a specific interest in somatic mutations of the hematopoietic stem cell. Clinically, she had a clinic dedicated to individuals who are at high risk for developing a myeloid malignancy including individuals with evidence of clonal hematopoiesis (Clonal Hematopoiesis of Indeterminant Potential). Her preclinical studies funded by the NHLBI (K08 award) utilizes primary patient samples and murine models to evaluate the role of TP53 pathway in myeloid malignancy and the best methods to target this pathway. Dr. Marcellino is Director of the Tisch Cancer Institute Hematological Malignancies Tissue Bank and the NCI funded P01 funded Myeloproliferative Neoplasms-Research Consortium Tissue Bank (PI Ronald Hoffman).
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Cancer, Cancer Genetics, Hematopoiesis, Inflammation, Leukemia
Multi-Disciplinary Training Areas
Cancer Biology [CAB]
About Me
Bridget K. Marcellino, MD, PhD is an assistant professor in the Department of Medicine, Division of Hematology & Oncology at the Icahn School of Medicine at Mount Sinai. She is a physician scientist who is focused on elucidating the mechanisms driving the formation and progression of myeloid malignancies, with a specific interest in somatic mutations of the hematopoietic stem cell. Clinically, she had a clinic dedicated to individuals who are at high risk for developing a myeloid malignancy including individuals with evidence of clonal hematopoiesis (Clonal Hematopoiesis of Indeterminant Potential). Her preclinical studies funded by the NHLBI (K08 award) utilizes primary patient samples and murine models to evaluate the role of TP53 pathway in myeloid malignancy and the best methods to target this pathway. Dr. Marcellino is Director of the Tisch Cancer Institute Hematological Malignancies Tissue Bank and the NCI funded P01 funded Myeloproliferative Neoplasms-Research Consortium Tissue Bank (PI Ronald Hoffman).
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Cancer, Cancer Genetics, Hematopoiesis, Inflammation, Leukemia
Multi-Disciplinary Training Areas
Cancer Biology [CAB]
Clinical Focus
- Bone Marrow Biopsy
- Clonal Hematopoiesis (CH)
- Cytopenia
- Essential Thrombocythemia
- Essential Thrombocytosis
- Genetic risk for blood disease
- Myeloproliferative Disorders
- Myeloproliferative Neoplasm
- Polycythemia Vera
Show More
Education
MD, Icahn School of Medicine at Mount Sinai
Residency, Internal Medicine
Icahn School of Medicine At Mount Sinai
Fellowship, Hematology & Oncology
Icahn School of Medicine At Mount Sinai
Certifications
American Board of Internal Medicine
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Union Square10 Union Square East, Suite 4C, New York, NY, 10003
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Marcellino during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Cellarity
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Marcellino during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Cellarity
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.